Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Validation of a Methodology Using Isometric Dynamometer for Ankle STrength Assessment to Quantify LDH-induced Paresis (VAST-LDH)

12 de agosto de 2026 atualizado por: Teppo Jarvinen, Helsinki University Central Hospital

Validation of a Methodology Using Isometric Dynamometer for Ankle Strength Assessment to Quantify LDH-induced Paresis

Lumbar disc herniation (LDH) is a common condition that may cause lower limb motor weakness (paresis), particularly affecting ankle dorsiflexion and plantarflexion. Although motor deficits are clinically important and may influence treatment decisions, objective and standardized methods for quantifying the severity of paresis are lacking. Current clinical assessment mainly relies on manual muscle testing, which is subjective and has limited sensitivity, while isokinetic dynamometry, the reference standard for muscle strength assessment, is expensive and impractical for routine clinical use.

This prospective validation study aims to evaluate a clinically feasible isometric ankle strength measurement method based on a handheld dynamometer fixed with an external strap to eliminate examiner-dependent resistance. The study will be conducted in two sequential phases. First, validity and reliability of the method will be established in healthy adult volunteers by comparing measurements with those obtained using an isokinetic dynamometer. Second, the method will be applied in patients with LDH-induced lower limb paresis to determine its performance across a broader range of muscle strength values and its clinical applicability.

Outcome measures include maximal isometric ankle dorsiflexion and plantarflexion force, time to peak force, manual muscle testing (Medical Research Council scale), patient-reported weakness using a Numeric Rating Scale, Lower Extremity Functional Scale (LEFS) scores, and functional ankle strength tests. Validity will be assessed using correlation analyses and Bland-Altman agreement analysis, while intra- and inter-rater reliability will be evaluated using intraclass correlation coefficients, coefficient of variation, standard error of measurement, and minimum detectable change.

The study seeks to establish a reliable, valid, and clinically practical method for objective assessment of ankle muscle strength in patients with LDH-induced paresis. Such a method could improve clinical evaluation, enable objective monitoring of recovery, facilitate future clinical research, and support treatment decision-making.

Visão geral do estudo

Status

Inscrevendo-se por convite

Descrição detalhada

Lumbar disc herniation (LDH) is one of the most common causes of lumbar radiculopathy and may result in lower limb motor weakness due to nerve root compression. While radicular pain often improves with conservative treatment, motor deficits may persist, recover slowly, or require surgical intervention. Despite the clinical importance of paresis, objective quantification of muscle weakness remains challenging because no standardized, practical, and validated measurement method is routinely available for clinical use.

Current clinical assessment primarily relies on manual muscle testing (MMT), which uses an ordinal grading system and is inherently subjective. MMT is limited by examiner experience, strength, and the inability to detect small but clinically meaningful changes in muscle function. Isokinetic dynamometry is widely regarded as the reference standard for objective muscle strength assessment because of its high accuracy and reproducibility. However, the equipment is expensive, non-portable, requires specialized training, and is therefore unsuitable for routine outpatient assessment or repeated follow-up measurements.

This study aims to validate a portable isometric ankle strength measurement method using a handheld dynamometer secured with an external fixation strap, minimizing examiner-related variability. The ultimate goal is to develop a clinically feasible method capable of objectively quantifying ankle dorsiflexion and plantarflexion strength in patients with LDH-induced paresis.

The study is designed as a prospective observational validation study conducted at Helsinki University Hospital. It consists of two consecutive phases.

During the first phase, healthy adult volunteers will undergo repeated ankle strength measurements using both the investigational handheld dynamometer method and an isokinetic dynamometer. This phase will establish criterion validity by comparing the handheld measurements with the reference standard. In addition, intra-rater and inter-rater reliability of the handheld method will be assessed through repeated measurements performed by different examiners.

If adequate validity and reliability are demonstrated, the second phase will recruit patients diagnosed with lumbar disc herniation presenting with clinically verified lower limb paresis. The objective of this phase is to evaluate whether the measurement method performs across the full spectrum of muscle weakness encountered in clinical practice and to determine its clinical relevance.

Primary measurements include maximal isometric ankle dorsiflexion and plantarflexion force and time to peak force. Secondary assessments include manual muscle testing according to the Medical Research Council grading system, patient-reported weakness using an 11-point Numeric Rating Scale, Lower Extremity Functional Scale (LEFS), and functional performance tests consisting of repeated toe raises and heel raises.

Criterion validity will be evaluated by comparing handheld dynamometer measurements with isokinetic dynamometer measurements using Pearson or Spearman correlation coefficients, linear regression analyses, and Bland-Altman plots to assess agreement and systematic bias. Construct validity will be examined by correlating objective strength measurements with patient-reported weakness, LEFS scores, and functional performance tests. Reliability will be assessed using intraclass correlation coefficients for both intra-rater and inter-rater agreement, together with coefficient of variation, standard error of measurement, and minimum detectable change.

Approximately 35 healthy volunteers and 35 patients with LDH-induced paresis will be recruited to allow for participant dropout while maintaining adequate statistical power based on previous validation studies.

The study involves no therapeutic intervention and poses minimal risk. Participants will undergo standardized muscle strength testing and complete patient-reported outcome measures. Any discomfort, such as muscle cramps or transient fatigue during testing, will be documented. Participants demonstrating clinically significant deterioration in muscle strength during the study will be referred for further clinical evaluation according to standard practice.

By establishing a valid, reliable, and practical method for objective ankle strength assessment, this study aims to improve the evaluation and longitudinal monitoring of patients with LDH-induced paresis. The validated methodology may facilitate future clinical trials, improve outcome assessment, enable earlier recognition of neurological recovery or deterioration, and support evidence-based treatment decisions in patients with lumbar disc herniation.

Tipo de estudo

Intervencional

Inscrição (Estimado)

70

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Uusimaa
      • Helsinki, Uusimaa, Finlândia, 00290
        • Helsinki University Central Hospital

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Sim

Descrição

First phase

Inclusion Criteria:

  • Aged 18-65 years old
  • No pathology affecting ankle dorsiflexion or plantarflexion strength

Exclusion Criteria:

- Pathology affecting ankle dorsiflexion or plantarflexion strength

Second phase

Inclusion Criteria:

  • Aged 18-65 years old
  • LDH-induced muscle weakness of ankle dorsiflexion or plantarflexion

Exclusion Criteria:

- No muscle weakness induced by herniated lumbar disc

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Outro
  • Alocação: N / D
  • Modelo Intervencional: Atribuição de grupo único
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Outro: Study participant
Person participating in validity and reliability assessment
Ankle dorsiflexion and plantarflexion isometric maximal voluntary contraction strength test

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Criterion validity of the isometric handheld dynamometer
Prazo: At baseline (first measurement session; Day 0)
Agreement between the investigational isometric handheld dynamometer (HHD) measurement method and the reference standard isokinetic dynamometer (IKD) for maximal ankle dorsiflexion and plantarflexion strength.
At baseline (first measurement session; Day 0)
Construct validity of the handheld dynamometer
Prazo: At baseline (first measurement session; Day 0)
Correlation of HHD measurements with patient-reported weakness (Numerical Rating Scale), Lower Extremity Functionality Scale questionnaire, manual muscle testing (Medical Research Council grade) and functional ankle performance tests.
At baseline (first measurement session; Day 0)
Intra-rater reliability of the handheld dynamometer
Prazo: At baseline (Day 0) and at the second measurement session, within 7 days after baseline
Test-retest reliability of ankle dorsiflexion and plantarflexion strength measurements obtained by the same examiner.
At baseline (Day 0) and at the second measurement session, within 7 days after baseline
Inter-rater reliability of the handheld dynamometer
Prazo: At the second measurement session, within 7 days after baseline
Agreement between measurements performed by different examiners
At the second measurement session, within 7 days after baseline

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Maximal isometric ankle dorsiflexion strength
Prazo: At baseline (first measurement session; Day 0)
Maximum voluntary isometric dorsiflexion force measured using the handheld dynamometer
At baseline (first measurement session; Day 0)
Maximal isometric ankle plantarflexion strength
Prazo: At baseline (first measurement session; Day 0)
Maximum voluntary isometric plantarflexion force measured using the handheld dynamometer.
At baseline (first measurement session; Day 0)
Time to peak force
Prazo: At baseline (first measurement session; Day 0)
Time required to reach maximal voluntary isometric force during dorsiflexion and plantarflexion.
At baseline (first measurement session; Day 0)
Manual Muscle Testing (Medical Research Council scale)
Prazo: At baseline (first measurement session; Day 0)
Ankle muscle strength (plantarflexion and dorsiflexion) assessed using the Medical Research Council (MRC) 0-5 manual muscle testing scale (0 = no muscle contraction, 5 = normal strength)
At baseline (first measurement session; Day 0)
Participant-reported lower limb weakness (Numeric Rating Scale)
Prazo: At baseline (first measurement session; Day 0)
Self-reported severity of lower limb weakness measured using an 11-point Numeric Rating Scale (0 = no weakness, 10 = worst imaginable weakness).
At baseline (first measurement session; Day 0)
Participant reported function (Lower Extremity Functional Scale, LEFS)
Prazo: At baseline (first measurement session; Day 0)
Lower extremity function assessed using the Lower Extremity Functional Scale (score range 0-80, higher scores indicate better function).
At baseline (first measurement session; Day 0)
Functional ankle performance testing (heel raises, toe raises)
Prazo: At baseline (first measurement session; Day 0)
Functional ankle performance assessed by the maximum number of heel raises (plantarflexion) and toe raises (dorsiflexion).
At baseline (first measurement session; Day 0)
Participant-reported discomfort during measurements
Prazo: From baseline (Day 0) through completion of the second measurement session, up to 7 days after baseline
Occurrence of adverse symptoms during testing, including but not limited to muscle cramps, discomfort, or pain.
From baseline (Day 0) through completion of the second measurement session, up to 7 days after baseline

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

10 de agosto de 2026

Conclusão Primária (Estimado)

1 de outubro de 2026

Conclusão do estudo (Estimado)

1 de dezembro de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

8 de julho de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

12 de agosto de 2026

Primeira postagem (Real)

13 de agosto de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

13 de agosto de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

12 de agosto de 2026

Última verificação

1 de agosto de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

SIM

Descrição do plano IPD

De-identified individual participant data underlying the results reported in the publication, including ankle strength measurements, functional outcome measures, and participant characteristics.

Prazo de Compartilhamento de IPD

10 years after publication

Critérios de acesso de compartilhamento IPD

Researchers who provide a methodologically sound research proposal.

Data will be available upon reasonable request to the principal investigator, subject to institutional approval, applicable legislation, and a data sharing agreement.

Tipo de informação de suporte de compartilhamento de IPD

  • PROTOCOLO DE ESTUDO
  • SEIVA

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever